Walter koroshetz, a former colleague from massachusetts general hospital—hold a us patent for inventing a method and apparatus for thermally affecting.
Webcalled donanemab, this treatment from eli lilly will be sold under its brand name, kisunla, and works as an intravenous infusion injected every four weeks.